The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 23, 2021

Filed:

May. 14, 2021
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Gregory Hinkle, Plymouth, MA (US);

Frederic Tremblay, Boston, MA (US);

Noura S. Abul-Husn, New York, NY (US);

Omri Gottesman, Rancho Santa Fe, CA (US);

Alexander Li, White Plains, NY (US);

Xiping Cheng, Northvale, NJ (US);

Yurong Xin, Ashland, MA (US);

Jesper Gromada, Concord, MA (US);

Frederick E. Dewey, Winchester, MA (US);

Aris Baras, Bedford Corners, NY (US);

Alan Shuldiner, Baltimore, MD (US);

Stuart Milstein, Arlington, MA (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 2310/315 (2013.01); C12N 2320/50 (2013.01);
Abstract

The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the HSD17B13 gene, as well as methods of inhibiting expression of HSD17B13, and methods of treating subjects that would benefit from reduction in expression of HSD17B13, such as subjects having a HSD17B13-associated disease, disorder, or condition, using such dsRNA compositions.


Find Patent Forward Citations

Loading…